101 related articles for article (PubMed ID: 8021497)
21. Effect of MHC class I and CD8 cell deficiency on experimental autoimmune myasthenia gravis pathogenesis.
Shenoy M; Kaul R; Goluszko E; David C; Christadoss P
J Immunol; 1994 Dec; 153(11):5330-5. PubMed ID: 7963585
[TBL] [Abstract][Full Text] [Related]
22. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
[TBL] [Abstract][Full Text] [Related]
23. Protective immunity from naive CD8+ T cells activated in vitro with MHC class I binding immunogenic peptides and IL-2 in the absence of specialized APCs.
Hauser C; Zipprich F; Leblond I; Wirth S; Hügin AW
J Immunol; 1999 Jul; 163(1):330-6. PubMed ID: 10384132
[TBL] [Abstract][Full Text] [Related]
24. Class I HLA folding and antigen presentation in beta 2-microglobulin-defective Daudi cells.
Martayan A; Sibilio L; Tremante E; Lo Monaco E; Mulder A; Fruci D; Cova A; Rivoltini L; Giacomini P
J Immunol; 2009 Mar; 182(6):3609-17. PubMed ID: 19265139
[TBL] [Abstract][Full Text] [Related]
25. Alloantigen presentation by individual clones of mouse splenic macrophages. Selective expression of IL-1 alpha in response to CD8+ T cell-derived IFN-gamma defines the alloantigen-presenting phenotype.
McCormack JM; Askew D; Walker WS
J Immunol; 1993 Nov; 151(10):5218-27. PubMed ID: 8228220
[TBL] [Abstract][Full Text] [Related]
26. Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice.
Yoshimura A; Shiku H; Nakayama E
J Immunol; 1993 Jun; 150(11):4900-10. PubMed ID: 8496592
[TBL] [Abstract][Full Text] [Related]
27. Absence of tapasin alters immunodominance against a lymphocytic choriomeningitis virus polytope.
Boulanger DS; Oliveira R; Ayers L; Prior SH; James E; Williams AP; Elliott T
J Immunol; 2010 Jan; 184(1):73-83. PubMed ID: 19949070
[TBL] [Abstract][Full Text] [Related]
28. Apparent MHC-independent stimulation of CD8+ T cells in vivo during latent murine gammaherpesvirus infection.
Coppola MA; Flaño E; Nguyen P; Hardy CL; Cardin RD; Shastri N; Woodland DL; Blackman MA
J Immunol; 1999 Aug; 163(3):1481-9. PubMed ID: 10415050
[TBL] [Abstract][Full Text] [Related]
29. CD8+ T lymphocyte-mediated antiviral immunity in mice as a result of injection of recombinant viral proteins.
Weidt G; Utermöhlen O; Zerrahn J; Reimann J; Deppert W; Lehmann-Grube F
J Immunol; 1994 Sep; 153(6):2554-61. PubMed ID: 8077665
[TBL] [Abstract][Full Text] [Related]
30. Quantification of epitope-specific MHC class-II-restricted T cells following lymphocytic choriomeningitis virus infection.
Kamperschroer C; Quinn DG
Cell Immunol; 1999 May; 193(2):134-46. PubMed ID: 10222055
[TBL] [Abstract][Full Text] [Related]
31. Germ-line transmission of a disrupted beta 2-microglobulin gene produced by homologous recombination in embryonic stem cells.
Zijlstra M; Li E; Sajjadi F; Subramani S; Jaenisch R
Nature; 1989 Nov; 342(6248):435-8. PubMed ID: 2685607
[TBL] [Abstract][Full Text] [Related]
32. Transfer of lymphocytic choriomeningitis disease in beta 2-microglobulin-deficient mice by CD4+ T cells.
Quinn DG; Zajac AJ; Frelinger JA; Muller D
Int Immunol; 1993 Oct; 5(10):1193-8. PubMed ID: 7903551
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of recovery from acute virus infection. IX. Clearance of lymphocytic choriomeningitis (LCM) virus from the feet of mice undergoing LCM virus-specific delayed-type hypersensitivity reaction.
Moskophidis D; Fang L; Gossmann J; Lehmann-Grube F
J Gen Virol; 1989 Dec; 70 ( Pt 12)():3305-16. PubMed ID: 2575136
[TBL] [Abstract][Full Text] [Related]
34. Antiviral immune responses of lymphocytic choriomeningitis virus-infected mice lacking CD8+ T lymphocytes because of disruption of the beta 2-microglobulin gene.
Lehmann-Grube F; Löhler J; Utermöhlen O; Gegin C
J Virol; 1993 Jan; 67(1):332-9. PubMed ID: 8093219
[TBL] [Abstract][Full Text] [Related]
35. The role of CD4+ T cells in cell-mediated immunity to LCMV: studies in MHC class I and class II deficient mice.
Christensen JP; Marker O; Thomsen AR
Scand J Immunol; 1994 Oct; 40(4):373-82. PubMed ID: 7939408
[TBL] [Abstract][Full Text] [Related]
36. Lack of MHC class I complex expression has no effect on spread and control of cytomegalovirus infection in vivo.
Polić B; Jonjić S; Pavić I; Crnković I; Zorica I; Hengel H; Lucin P; Koszinowski UH
J Gen Virol; 1996 Feb; 77 ( Pt 2 )():217-25. PubMed ID: 8627225
[TBL] [Abstract][Full Text] [Related]
37. Lymphocytic choriomeningitis virus induces a chronic wasting disease in mice lacking class I major histocompatibility complex glycoproteins.
Doherty PC; Hou S; Southern PJ
J Neuroimmunol; 1993 Jul; 46(1-2):11-7. PubMed ID: 8103060
[TBL] [Abstract][Full Text] [Related]
38. The assembly of functional beta(2)-microglobulin-free MHC class I molecules that interact with peptides and CD8(+) T lymphocytes.
Schell TD; Mylin LM; Tevethia SS; Joyce S
Int Immunol; 2002 Jul; 14(7):775-82. PubMed ID: 12096037
[TBL] [Abstract][Full Text] [Related]
39. Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells.
Koller BH; Marrack P; Kappler JW; Smithies O
Science; 1990 Jun; 248(4960):1227-30. PubMed ID: 2112266
[TBL] [Abstract][Full Text] [Related]
40. Cutting edge: B cells promote CD8+ T cell activation in MRL-Fas(lpr) mice independently of MHC class I antigen presentation.
Chan OT; Shlomchik MJ
J Immunol; 2000 Feb; 164(4):1658-62. PubMed ID: 10657607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
